ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,659.55
      0.50%
      US Tech 100
      19,843.60
      -0.01%
      Dow Jones
      40,930.53
      1.79%
      Brent Oil
      83.255
      -1.29%
      Bitcoin
      64,754.56
      -0.16%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alaunos Therapeutics Inc (TCRT)

      7. Alaunos Therapeutics Inc (TCRT) Financials

      Alaunos Therapeutics Inc

      Alaunos Therapeutics Inc (TCRT)

      NASDAQ
      0.6102
      -0.0678
      ( -10.00% )
      Updated: 15:34:35
      Delayed by 15 minutes

      Alaunos Therapeutics Inc Financial Summary

      The current TCRT market cap is 9.77M. The company's latest EPS is USD -2.1945 and P/E is -0.28.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0249k054k1,000
      Operating Income -9.67M-7.98M-8.67M-7.95M-1.74M
      Net Income -10.05M-8.77M-8.48M-7.84M-1.68M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00398k2.92M303k
      Operating Income -57.86M-80.36M-78.75M-35.24M-34.27M
      Net Income -117.8M-79.98M-78.75M-37.73M-35.14M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 48.64M27.93M19.44M8.26M6.04M
      Total Liabilities 19.13M6.28M5.54M1.96M1.24M
      Total Equity 29.51M21.65M13.9M6.31M4.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 109.11M146.35M94.87M64.94M8.26M
      Total Liabilities 14.1M22.36M36.81M26.38M1.96M
      Total Equity 95.01M123.98M58.06M38.56M6.31M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.38M-16.38M-22.76M-30.14M-1.92M
      Investing -23k-158k-157k1.35M N/A
      Financing -6.16M-18.14M-18.14M-18.14M N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -40.85M-57.01M-61.47M-29.23M-30.14M
      Investing -284k-9.78M-3.32M-193k1.35M
      Financing 59.15M102.12M25.78M6.37M-18.14M

      Stats and Ratios

      Market Cap 9.77M
      Price to Earnings Ratio -0.28
      Price to Sales Ratio 32.28
      Price to Cash Ratio 1.61
      Price to Book Ratio 1.55
      Dividend Yield -

      Share Statistics

      Shares Outstanding 16.01M
      Average Volume (1 week) 65.3k
      Average Volume (1 Month) 57.42k
      52 Week Change -91.53%
      52 Week High 7.50
      52 Week Low 0.5622
      Spread (Intraday) 0 (0.03%)

      Company Info

      Company Name Alaunos Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.ziopharm.com
      Industry spec outpatient facility,nec (8093)